Figure 5.
Incidence of serious adverse events (A), Treatment discontinuation (B), and Hypoglycemia (C) in patients who received dulaglutide compared to liraglutide
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.